8 Jul 2022 15:33
GSK plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | |||||
a) | Name | Ms E Walmsley | ||||
b) | Position/status | Chief Executive Officer | ||||
c) | Initial notification/ amendment | Initial notification | ||||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | GSK plc | ||||
b) | LEI | 5493000HZTVUYLO1D793 | ||||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | |||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 Â | ||||
b) | Nature of the transaction | Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 1 July 2022 on Ordinary Shares held in the Company's Performance Share Plan subject to a 2-year holding period  | ||||
c) | Price(s) and volume(s) |
   | ||||
d) | Aggregated information Aggregated volume Price | N/A (single transaction) Â Â Â Â Â | ||||
e) | Date of the transaction | 2022-07-05 | ||||
f) | Place of the transaction  | London Stock Exchange (XLON) | ||||
Â
Â
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Mr I Mackay | |||
b) | Position/status | Chief Financial Officer | |||
c) | Initial notification/ amendment | Initial notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GSK plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882 Â Â | |||
b) | Nature of the transaction | Acquisition of Ordinary Shares following the re-investment of dividends paid to shareholders on 1 July 2022 on Ordinary Shares held in the Company's Performance Share Plan subject to a 2-year holding period  | |||
c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
£17.8560 | 1,213.975 | ||||
d) | Aggregated information  | N/A (single transaction)  | |||
 Aggregated volume Price |   | ||||
e) | Date of the transaction | 2022-07-05 | |||
f) | Place of the transaction  | London Stock Exchange (XLON) | |||
Â
Glaxosmithkline (GSK)